Two Sigma Securities, LLC Kintara Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.14 - $6.8 $4,159 - $202,048	29,713 New	29,713 $3,000
Q1 2022 May 16, 2022	SELL	$0.31 - $0.55 $14,464 - $25,663	-46,661 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.51 - $1.04 $23,797 - $48,527	46,661 New	46,661 $24,000
Q2 2021 Aug 16, 2021	SELL	$1.26 - $2.4 $15,235 - $29,020	-12,092 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.32 - $2.74 $15,961 - $33,132	12,092 New	12,092 $21,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.